ApoEdp selectively blocked VEGF-induced Flk-1 receptor activation and the downstream angiogenic signalling pathway of c-Src-Akt-eNOS, FAK, and Erk1/2 which promote tumor development. The gene discussed is SRC; the disease is neoplasm.